This week, the company doctors also started vaccinating against corona.
However, the vaccine is usually a scarce commodity.
Erding - As one of the first companies in the district, the private brewery Erdinger Weißbräu started a vaccination campaign including its own vaccination center on Wednesday.
According to a press release, a task force led by company doctor Dr.
Jörg Jakob and Lars Goschenhofer, Head of Safety, Health and Environment, have been involved in the campaign for several weeks.
For this purpose, among other things, a vaccination center "according to all currently applicable hygienic standards" was built directly on the brewery site on Franz-Brombach-Straße, the supply of medical materials was ensured and transparent communication with the workforce began in good time.
All colleagues were informed early and in detail about the vaccination campaign via the intranet and training systems.
"Since then, everyone has had the opportunity to register for an appointment online via our internal registration page," says Goschenhofer and is pleased: "The campaign has met with great interest so far and has been very well received." Only the vaccine from Biontech is vaccinated / Pfizer.
Dr.
Jakob: “We are very happy that we received a sufficiently large amount of vaccine from Biontech / Pfizer.
This means that we can really make a vaccination offer to all interested employees, regardless of age and gender. "
The Heinz group of companies with employees from the Erding district is also hoping for sufficient vaccine in the near future.
On Monday, the company claims to have received 20 vaccination doses so far and vaccinated them to employees at the Moosburg, Altheim, Wang and Landshut locations.
Heinz had been actively promoting this topic since February.
Employee surveys on vaccination requirements have shown that the proportion of those willing to be vaccinated is around 80 percent.
One would have liked to have started vaccinations earlier, "but we are pleased that we were finally able to start vaccinations in our company last Monday," says Managing Director Eduard Heinz.
He also emphasizes that company vaccinations are on the right track, but that additional doses must now be made available quickly so that a vaccination offer can really be made available to all those willing to vaccinate.
The company is slated to receive more cans from next week.
In addition, Heinz has been offering free corona tests at all company locations for several months in cooperation with local pharmacies. With this and with the company vaccinations one makes an important contribution to the health of the employees. "We hope that we will soon be able to return a little bit to normal as a result," says company doctor Dr. Peter Hamoshi.
The company Gewo Feinmechanik in Hörlkofen with almost 500 employees is at the forefront of the in-house pandemic fight. Just one day after the lockdown announcement, on March 17, 2020, the company had, according to a message, worked out an emergency plan to contain the corona and implemented it immediately. Since notebooks were made available to many employees in November 2019, an immediate home office and shift strategy in connection with a hygiene concept has so far been implemented very successfully.
Gewo is now offering all employees the option of vaccination with the Biontech / Pfizer vaccine on a voluntary basis - during working hours in the company's own premises by the company doctor. "We are proud that we were able to get the in-house vaccination up and running so quickly," say the two managing directors Stefan and Andreas Woitzik. In this way, they could protect their employees in the company as well as in their private lives. "It is important to us that our workforce feels comfortable and safe in the company," emphasize the Woitziks.
However, the furniture manufacturer Himolla in Taufkirchen is not quite that far yet.
Here, together with the company medical center, we are still in the planning phase for the vaccinations, reports Robert Unterreithmeier, who works in the company as a company paramedic in the company.
The really big unknown is the vaccine.
"When we will start vaccinating and how much we will have vaccine available, that is currently not foreseeable," says Unterreithmeier.
vam
